RGC
Regencell Bioscience Holdings Limited
$12.06
0.53
(4.63%)
| Exchange: | |
| Market Cap: | 5.965B |
| Shares Outstanding: | 480.4M |
About The Company
| Sector: | Healthcare | |||||
| Industry: | Drug Manufacturers – Specialty & Generic | |||||
| CEO: | Yat-Gai Au | |||||
| Full Time Employees: | 12 | |||||
| Address: |
|
|||||
| Website: | https://www.regencellbioscience.com |
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Click to read more…
Revenue Segmentation
EPS
Earnings Call
Income Statement
(* All numbers are in thousands)
Balance Sheet
(* All numbers are in thousands)
Cash Flow Statement
(* All numbers are in thousands)
Analyst Estimates
(* All numbers are in thousands)
